Efficacy of Alcaftadine 0.25% (AGN-229666) for Once-daily Prevention of Cedar-Pollen Allergic Conjunctivitis: A Phase 3 Randomized Study
Article in Ocular Immunology and Inflammation (June 2020)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in Ocular Immunology and Inflammation (June 2020)
Article in BMC Ophthalmology (July 2019)
Article in Ocular Immunology and Inflammation (March 2018)